Cellebrite DI Ltd (CLBT) Stock Analysis
Verdict: HOLD
Post-earnings capitulation meets fortress margins: a high-quality DI leader oversold on short-term guidance fears.
Investment score: 62/100
Analysis as of
Is Cellebrite DI Ltd stock worth reviewing? AI model thesis
The model score of 62/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 85/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 70/100 (weight 15%)
Cellebrite DI Ltd opportunities and risks
What speaks for CLBT
- Elite Margin Profile
What speaks against CLBT
- Guidance Deceleration Persistence
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CLBT | 37.0x | 5.4x | 20.2x | 83.9% | 14.5% | 5.7% |
| PGY | 14.3x | 1.4x | 20.2x | 40.6% | 9.6% | 14.1% |
| RSKD | n/a | 2.7x | 487.8x | 50.8% | -4.2% | 4.8% |
| SMWB | n/a | 2.7x | n/a | 79.7% | -7.4% | 1.9% |
| Peer median | n/a | 2.7x | 20.2x | 50.8% | -4.2% | 4.8% |
Frequently asked questions about Cellebrite DI Ltd (CLBT)
Is CLBT stock a good investment?
The cached TradeMates AI model rates Cellebrite DI Ltd as HOLD with an investment score of 62/100. The model score of 62/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.
Is CLBT stock a buy?
The TradeMates model verdict for CLBT is HOLD with an investment score of 62/100. Treat this as a model signal to review, not a personal buy recommendation.